One Million Courses of Therapeutic Drug ‘Slated for Delivery’ to Canada this Year: Pfizer January 19, 2022 PCChannel Canadian News Canada News Pfizer Canada’s Kevin Mohamed joined Power & Politics Monday to discuss the Canadian delivery schedule for its COVID-19 therapeutic drug Paxlovid, which received Health Canada approval today. Credit CBC News
